Evidence map›Paper›PMID 39528623›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats.

Jonathon C Arnold, Cassandra V Occelli Hanbury-Brown, Lyndsey L Anderson, Miguel A Bedoya-Pérez, Michael Udoh, Laura A Sharman, Joel S Raymond, Peter T Doohan, Adam Ametovski, Iain S McGregor

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jonathon C ArnoldLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia. jonathon.arnold@sydney.edu.au.ORCID http://orcid.org/0000-0002-0159-9997
Cassandra V Occelli Hanbury-BrownLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.
Lyndsey L AndersonLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.
Miguel A Bedoya-PérezLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.
Michael UdohLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.
Laura A SharmanLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.
Joel S RaymondLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.
Peter T DoohanLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-2122-7354
Adam AmetovskiLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.
Iain S McGregorLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal cannabis is being used worldwide and there is increasing use of novel cannabis products in the community. Cannabis contains the major cannabinoids, Δ

Indexed as

CannabinolHypnotics and SedativesSleepAnimalsCannabisDronabinolMalePolysomnographyPyridinesRatsRats, Sprague-DawleyReceptor, Cannabinoid, CB1Sleep, REMSleep StagesZolpidemCannabinolDronabinolHypnotics and SedativesPyridinesReceptor, Cannabinoid, CB1Zolpidem

Identifiers

PMID39528623
PMCPMC11736144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.